摘要
背景:紫杉醇于1993年获得批准,标志着萜类化合物在抗癌领域的广泛应用,在治疗难治性卵巢、乳腺癌和难治性卵巢癌方面仍具有重要意义。她的癌症。几十年来,其他突出的天然萜类化合物已成为现代乳腺癌药物治疗不可缺少的物质。然而,鉴于耐药性的快速演变,对需要细胞毒性化疗的晚期乳腺癌的治疗是一个主要的未得到满足的临床需要。因此,迫切需要有效的长效化疗药物. 目的:综述2012年1月1日至2016年12月31日期间天然萜类化合物的研究进展及其防治女性乳腺癌的机制。 结果:癌变是一个多步骤的过程,每一个阶段都表现出明显的表型变化。这次审查中记录的许多化学品被证明是非常重要的。体外和体内抑制不同乳腺癌细胞/肿瘤的增殖、迁移、抗凋亡、抑制肿瘤血管生成或转移。同时瞄准几个或所有这些癌症的进展可能是一种优势。据此,植物化物,如胸腺醌(8),肋古诺内酯(46),丹参酮IIA(132),雷公藤内酯醇(136),葫芦素B(179),细胞星形胶质(226)和番茄红素(238)引起了我们的注意。 结论:这些化合物有望克服乳腺癌的治疗失败。然而,尽管这些活动令人感兴趣,但还需要进一步的临床前研究。乳腺癌细胞/肿瘤模型的体外和体内研究。
关键词: 乳腺癌,抗癌,萜类化合物,致癌,乳腺癌治疗。
Current Medicinal Chemistry
Title:Natural Terpenoids Against Female Breast Cancer: A 5-year Recent Research
Volume: 25 Issue: 27
关键词: 乳腺癌,抗癌,萜类化合物,致癌,乳腺癌治疗。
摘要: Background: The approval of Taxol® in 1993 marked the great entrance of terpenoids in the anti-cancer area and this drug is still highly important in the treatment of refractory ovarian, breast and other cancers. Over decades, other prominent natural terpenoids have become indispensable for the modern pharmacotherapy of breast cancer. However, given the rapid evolution of drug resistance, effective treatments for advanced breast cancers requiring cytotoxic chemotherapy represent a major unmet clinical need. Therefore, innovative agents effective in long-term chemotherapy are urgently needed.
Objective: This review examines recent advances/research about natural terpenoids, and their mechanisms against female breast cancer over the period covering January 1st, 2012 to December 31st, 2016.
Results: Carcinogenesis constitutes a multistep process wherein each stage is characterized by distinct phenotypic changes. Numerous chemicals recorded in this review have been shown to significantly inhibit proliferation, migration, apoptosis resistance, tumor angiogenesis or metastasis in different breast cancer cells/tumours in vitro and in vivo. Targeting simultaneously several or all these aspects/steps of cancer progression could be an advantage. In line with this, phytochemicals such as thymoquinone (8), costunolide (46), tanshinone IIA (132), triptolide (136), cucurbitacin B (179), celastrol (226) and lycopene (238) had caught our attention.
Conclusion: These compounds appear to be promising to overcome breast cancer treatment failure. However, despite the interesting activities, additional preclinical investigations are needed in further breast cancer cell/tumor models in vitro and in vivo.
Export Options
About this article
Cite this article as:
Natural Terpenoids Against Female Breast Cancer: A 5-year Recent Research, Current Medicinal Chemistry 2018; 25 (27) . https://dx.doi.org/10.2174/0929867325666180214110932
DOI https://dx.doi.org/10.2174/0929867325666180214110932 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Overview of Chemistry and Therapeutic Potential of Non-Nitrogen Heterocyclics
as Anticonvulsant Agents
Current Neuropharmacology The Impact of the Activated Stroma on Pancreatic Ductal Adenocarcinoma Biology and Therapy Resistance
Current Molecular Medicine Crude Methanol Extract of Rosin Gum Exhibits Specific Cytotoxicity against Human Breast Cancer Cells via Apoptosis Induction
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Potential of Targeting PAK Signaling
Anti-Cancer Agents in Medicinal Chemistry The Role of Dietary Polyphenols in the Management of Inflammatory Bowel Disease
Current Pharmaceutical Biotechnology Some Recent Synthetic Development on Compounds with Potent Activities on Hormone-sensitive Breast Cancers
Current Organic Chemistry Clinicopathological Characteristics of Chinese Colorectal Cancer Patients under 30 Years of Age: Implication in Diagnosis and Therapy
Current Cancer Drug Targets Effects of Galbanic Acid on Proliferation, Migration, and Apoptosis of Glioblastoma Cells Through the PI3K/Akt/MTOR Signaling Pathway
Current Molecular Pharmacology Editorial (Thematic Issue: Treatment of Cancer in the Elderly)
Anti-Cancer Agents in Medicinal Chemistry Inflammation, Microenvironment, and the Immune System in Cancer Progression
Current Pharmaceutical Design The Effects of Soy Isoflavones in Postmenopausal Women: Clinical Review
Current Drug Therapy Melittin: A Natural Peptide with Expanded Therapeutic Applications
The Natural Products Journal Acridine Derivatives as Chemotherapeutic Agents
Current Medicinal Chemistry Tumor Escape from Immune Response: Mechanisms and Targets of Activity
Current Drug Targets Volumetric Analysis of the Hypothalamus, Amygdala and Hippocampus in Non-Suicidal and Suicidal Mood Disorder Patients – A Post-Mortem Study
CNS & Neurological Disorders - Drug Targets Adhesion Molecules as Targets for the Treatment of Neoplastic Diseases
Current Pharmaceutical Design BSA Au Clusters as a Probe for Enhanced Fluorescence Detection Using Multipulse Excitation Scheme
Current Pharmaceutical Biotechnology Polysaccharide-Based Materials Associated with or Coordinated to Gold Nanoparticles: Synthesis and Medical Application
Current Medicinal Chemistry Combined 3D-QSAR, Pharmacophore and Docking Studies on Benzenesulfonamide Derivatives as Potent 12-Lipoxygenase Inhibitors
Letters in Drug Design & Discovery Monoclonal Antibodies as Innovative Therapeutics
Current Pharmaceutical Biotechnology